Vaccine trial resumes as virus continues grim march 09/13/2020 Health News, Clinical trials of one of the most advanced experimental COVID-19 vaccines resumed Saturday after a...
AstraZeneca starts UK COVID-19 drug trial 09/04/2020 Health News, Pharma giant AstraZeneca said Tuesday it had begun a clinical trial of a drug designed...
Trial finds drug safe and effective in treating hepatitis C during pregnancy 07/28/2020 Health News, Critics of the new recommendation to screen all pregnant women for hepatitis C—a lifelong infection...
New lung cancer trial to help predict relapse 05/26/2020 Health News, A new international Phase 3 clinical trial coordinated by Crick Senior Group Leader and Cancer...
European clinical trial starts on possible coronavirus treatments 03/23/2020 Health News, This scanning electron microscope image shows SARS-CoV-2 (yellow)—also known as 2019-nCoV, the virus that causes...
Boy with 'dementia' recognises parents again after clinical trial 11/12/2019 Health News, Boy with 'childhood dementia' who had forgotten his parents can now recognise them again after...
New breath test for cancer currently under trial 01/07/2019 Health News, Researchers from the Cancer Research United Kingdom Cambridge Institute have recently developed an innovative breath...
Pfizer Initiates Phase 2b/3 Clinical Trial for PF-06651600, an Oral JAK3 Inhibitor, for the Treatment of Patients with Moderate to Severe Alopecia Areata 01/05/2019 Medications, January 3, 2019 -- Pfizer Inc. (NYSE: PFE) announced today the initiation of a Phase...
Incyte Announces First Patient Treated in Phase 3 Clinical Trial Program for Ruxolitinib Cream in Atopic Dermatitis 12/28/2018 Medications, WILMINGTON, Del.--(BUSINESS WIRE)--Dec. 20, 2018-- Incyte (Nasdaq:INCY) today announced that the first patient has been...
Blueprint Medicines Announces Updated Results from Ongoing EXPLORER Clinical Trial of Avapritinib Demonstrating Broad Clinical Activity and Significant Symptom Reductions in Patients with Systemic Mastocytosis 12/04/2018 Medications, CAMBRIDGE, Mass., Dec. 2, 2018 /PRNewswire/ -- Blueprint Medicines Corporation (NASDAQ: BPMC), a leader in...